biotech · Glaucoma · Hepatocellular Carcinoma · AEON
AEON Biopharma
AEON Biopharma is a biotech organization headquartered in irvine, USA. It trades on NYSE under ticker AEON. Primary therapeutic focus areas include Glaucoma, Hepatocellular Carcinoma, Cervical Dystonia, Migraine, Congeni
irvine, USA HQ
11 Employees
Public company Type
AEON · NYSE Ticker
Company details
- Status
- Public
- HQ
- irvine, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 8
- Patents
- 9
Use of Mitomycin-C (MMC) in trabeculectomy
Approved · small molecule · Glaucoma
Use of Mitomycin-C (MMC) in trabeculectomy for Glaucoma is a Approved program (small_molecule) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Internal code AAE-CT-USA-2010-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AEON Biopharma
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Glaucoma
- Status
- completed
- Trials
- 1